EU-Backed META-BRAIN Project Uses Nanotech to Revolutionize Mental Health Treatments

A new EU-funded research project is exploring safer, non-invasive treatments for mental health disorders using cutting-edge nanotechnology. The META-BRAIN initiative, led by neuroscientist Mavi Sanchez-Vives, brings together experts from five countries to develop wireless brain stimulation methods that could avoid surgery and reduce side effects.

The project focuses on two key approaches. One involves using focused ultrasound waves to stimulate the brain externally. The other relies on magnetoelectric nanoparticles, which act as tiny wireless electrodes. These nanoparticles can be injected without surgery and controlled remotely via magnetic fields, allowing precise stimulation or inhibition of neural activity.

Neurological disorders affect 165 million people in Europe alone, with current treatments often limited and carrying significant risks. The META-BRAIN team, combining expertise in nanotechnology, ultrasound, and brain monitoring, aims to address this challenge by developing technology that could restore or compensate for lost senses and treat conditions more effectively.

The long-term goal is to create a system that can treat brain injuries and disorders immediately and non-invasively. If successful, the technology could transform care for neurological and neuropsychiatric conditions, offering a less invasive alternative to traditional methods.

The project runs until December 2026, with research institutions from Austria, Cyprus, Italy, Spain, and Switzerland collaborating on the development.

The META-BRAIN initiative could lead to major advances in brain disorder treatment by reducing the need for surgery and minimising side effects. If the technology proves successful, it may provide a faster, safer way to restore brain function and improve patients' quality of life.